10 employees
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
2016
$30M
from 3 investors over 3 rounds
Modis Therapeutics (A Zogenix Company) raised $30M on October 1, 2018
Investors: Osage University Partners (OUP), OrbiMed Advisors and F-Prime Capital Partners